Showing all 2 results
Acyclovir Dispersible Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated, Dispersible Tablets (often flavored/sweetened for palatability), packed in moisture-resistant blister strips.
Active Ingredient Strength Primary Clinical Use Acyclovir USP/BP/Ph.Eur. 200 mg HSV-1 & HSV-2 (Genital/Labial Herpes) Treatment Acyclovir USP/BP/Ph.Eur. 400 mg Recurrent HSV Suppression / Chronic Prophylaxis Acyclovir USP/BP/Ph.Eur. 800 mg Varicella (Chickenpox) & Herpes Zoster (Shingles) Excipients Crospovidone / Aspartame / Flavoring Agents Superdisintegrant / Sweetener / Taste-Masking Entacavir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the potent antiviral API.
Active Ingredient Strength Primary Clinical Function Entecavir (as Monohydrate) USP/Ph.Eur. 0.5 mg The Global Nucleoside-Naive Standard: The definitive ultra-micro-dose utilized for the daily, lifelong suppression of HBV in patients who have never received prior antiviral therapy. Entecavir (as Monohydrate) USP/Ph.Eur. 1.0 mg The Refractory & Cirrhosis Standard: Double-strength therapeutic payload utilized specifically for patients with Lamivudine-resistant HBV viremia or those suffering from decompensated liver cirrhosis. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Crospovidone / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically utilizing advanced multi-stage geometric dilution to ensure the microscopic 0.5mg payload is flawlessly distributed throughout the tablet matrix, preventing toxic “hot spots” or sub-therapeutic failures) *Pack Sizes: 3×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic hepatology dispensing regimens).
